FDA Approves First 3D Printed Drug

The U.S. Food and Drug Administration (FDA) approved the first 3D-printed drug this month, Spritam, designed to treat seizures brought on by epilepsy in children and adults. It was developed… Read More

Drugmakers and Insurers Attempt to Collaborate on Medication Prices

An increasing number of drugmakers, including Biogen Inc., Amgen Inc., and Sanofi are taking a proactive marketing approach–talking with insurers about costly medications still under development. With the price of these… Read More

Success Story: Peskin Pharmaceuticals

“Having access to a high level of technical expertise is not often possible in a small company, so plugging into ‘on-demand’ services, such as those offered by Zintro, is an… Read More

How Competition is Affecting Big Pharma

Although pharmaceutical companies have seen an improvement in drug pipelines, they are facing a new challenge. Namely, the first generation of blockbuster biological drugs manufactured by giants Bristol-Myers Squib, Eli… Read More

Study Questions Benefit of Some Dementia Drugs

A study published by the journal JAMA Internal Medicine found more than half of patients with advanced dementia are given drugs of questionable benefit on a regular basis. In addition,… Read More

Astra Zeneca Expects 75 Percent Revenue Growth by 2023

AstraZeneca CEO Pascal Soriot says that the company is on board for making $45 billion in revenue by 2023, which is 75 percent higher than 2013 sales. The reason for… Read More

Experts explain big pharma trends with biotechs

By Maureen Aylward An Ernst & Young report identifies two trends going on in biotech: an increase in research alliances between big pharma and start-up biotech firms and a rise in… Read More

What is driving pharmaceutical shortages?

By Maureen Aylward The Washington Post reports that there is a serious drug shortage of several important pharmaceuticals. We looked to our Zintro experts to tell us what is happening… Read More